Literature DB >> 634877

Penetration into bone and tissues of clindamycin phosphate.

P Baird, S Hughes, M Sullivan, I Willmot.   

Abstract

Clindamycin phosphate is an antibiotic which is effective against both Staphylococcus aureus and the anaerobic organisms. In thirteen patients, its concentration following joint replacement was measured by the agar diffusion method. In bone, the concentration was (mean +/- s.e. mean) 5.01 microgram/ml +/- 1.16, N=10; in capsule, 3.29 microgram/ml +/- 0.71, N=12; measured between 1.75 and 3.75 hr after intramuscular and intravenous injections, and in drainage fluid it amounted to 4.61 microgram/ml +/- 0.38, N=11 in 48 hr. Two patients developed diarrhoea which settled within a short period.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 634877      PMCID: PMC2425068          DOI: 10.1136/pgmj.54.628.65

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


  16 in total

1.  Clinical spectrum of pseudomembranous colitis.

Authors:  R C Cammerer; D L Anderson; H W Boyce; G E Burdick
Journal:  JAMA       Date:  1976-06-07       Impact factor: 56.272

2.  Antibacterial activity of clindamycin and lincomycin in human bone.

Authors:  K Dornbusch; A Carlström; H Hugo; A Lidström
Journal:  J Antimicrob Chemother       Date:  1977-03       Impact factor: 5.790

3.  Anaerobic bacteria in late infections after total hip arthroplasty.

Authors:  C Kamme; L Lidgren; L Lindberg; P A Mårdh
Journal:  Scand J Infect Dis       Date:  1974

4.  Letter: Clindamycin and pseudomembranous colitis.

Authors:  R F Wells; L E Cohen; C J McNeill
Journal:  Lancet       Date:  1974-01-12       Impact factor: 79.321

5.  Clinical and bacteriological studies with clindamycin.

Authors:  A M Geddes; F A Bridgwater; D N Williams; J Oon; G J Grimshaw
Journal:  Br Med J       Date:  1970-06-20

6.  Practical aspects of anaerobic sepsis.

Authors:  S M Finegold; J E Rosenblatt
Journal:  Medicine (Baltimore)       Date:  1973-07       Impact factor: 1.889

7.  Joint infection by anaerobic bacteria: a case report and review of the literature.

Authors:  I Ziment; A Davis; S M Finegold
Journal:  Arthritis Rheum       Date:  1969-12

8.  Pseudomembranous colitis.

Authors:  A B Price; D R Davies
Journal:  J Clin Pathol       Date:  1977-01       Impact factor: 3.411

9.  Comparison of gram-negative bacillary and staphylococcal osteomyelitis of the femur and tibia.

Authors:  P J Kelly; C J Wilkowske; J A Washington
Journal:  Clin Orthop Relat Res       Date:  1973-10       Impact factor: 4.176

10.  In vitro antimicrobial susceptibility of anaerobic bacteria isolated from clinical specimens.

Authors:  W J Martin; M Gardner; J A Washington
Journal:  Antimicrob Agents Chemother       Date:  1972-02       Impact factor: 5.191

View more
  6 in total

Review 1.  Pharmacokinetic and pharmacodynamic issues in the treatment of bacterial infectious diseases.

Authors:  P S McKinnon; S L Davis
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2004-03-10       Impact factor: 3.267

2.  Extended-duration dosing and distribution of dalbavancin into bone and articular tissue.

Authors:  Michael W Dunne; Sailaja Puttagunta; Craig R Sprenger; Chris Rubino; Scott Van Wart; James Baldassarre
Journal:  Antimicrob Agents Chemother       Date:  2015-01-05       Impact factor: 5.191

Review 3.  Systemic antibiotic therapy for chronic osteomyelitis in adults.

Authors:  Brad Spellberg; Benjamin A Lipsky
Journal:  Clin Infect Dis       Date:  2011-12-12       Impact factor: 9.079

4.  Pharmacokinetics of Clindamycin in Obese and Nonobese Children.

Authors:  Michael J Smith; Daniel Gonzalez; Jennifer L Goldman; Ram Yogev; Janice E Sullivan; Michael D Reed; Ravinder Anand; Karen Martz; Katherine Berezny; Daniel K Benjamin; P Brian Smith; Michael Cohen-Wolkowiez; Kevin Watt
Journal:  Antimicrob Agents Chemother       Date:  2017-03-24       Impact factor: 5.938

5.  The trends in antibiotic use by general dental practitioners in the Czech Republic (2006-2012).

Authors:  Rachel Pipalova; Jiri Vlcek; Radovan Slezak
Journal:  Int Dent J       Date:  2014-01-11       Impact factor: 2.607

6.  Antimicrobial susceptibilities and mechanisms of resistance of commensal and invasive Mycoplasma salivarium isolates.

Authors:  Li Xiao; Arthur H Totten; Donna M Crabb; Thomas Prescott Atkinson; Ken B Waites
Journal:  Front Microbiol       Date:  2022-08-01       Impact factor: 6.064

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.